Univest
Univest
  • Markets

Natural Capsules Share: Bull Case vs Bear Case for 2026

  • September 16, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Natural Capsules Share: Bull Case vs Bear Case for 2026

Natural Capsules Key Stats (16 Sep 2026)

Sector Empty Hard Gelatin and HPMC Capsules Manufacturing
Current Market Price Rs 172.16
52 Week High / Low Rs 296.00 / Rs 136.36
Market Cap (Rs Cr) 189
P/E Ratio (Industry P/E) not meaningful (loss making) (37.96)
Return on Equity -7.27%
Debt to Equity 0.49
EPS (TTM) Rs -23.85
Dividend Yield 0.00%
Book Value Rs 168.08
14 Day RSI 47.14

Quick Answer

The Natural Capsules bull case rests on trading close to book value, while the bear case points to sharp single session decline. At Rs 172.16, the stock sits between its 52 week low of Rs 136.36 and high of Rs 296.00, and both sides of the argument deserve a look before deciding. This article lays out the fundamentals and technical signals so you can weigh the Natural Capsules bull case against the risks yourself.

Natural Capsules operates in the empty hard gelatin and hpmc capsules manufacturing space, and its shares currently trade at Rs 172.16, placing the stock within a 52 week range of Rs 136.36 to Rs 296.00. For anyone building or reviewing a position, the Natural Capsules bull case and the bear case both come down to the same underlying numbers read in different lights, and this piece walks through both sides using the company’s latest valuation, profitability, and technical readings.

Rather than pushing you toward one conclusion, this Natural Capsules bull case analysis sets out what the bulls see in Natural Capsules shares and what the bears are watching, so you can match the picture against your own risk appetite and investment horizon. Understanding the Natural Capsules bull case thoroughly, alongside its counterpart, is essential before making any investment decision.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Natural Capsules Bull Case: Why Natural Capsules Could Move Higher
  • The Bear Case: Risks Facing Natural Capsules
  • Conclusion
  • Frequently Asked Questions
    • What is the Natural Capsules bull case for the stock?
    • What is the bear case for Natural Capsules shares?
    • What is the current share price of Natural Capsules?
    • What is the P/E ratio of Natural Capsules?
    • What is the return on equity for Natural Capsules?
    • Is Natural Capsules a debt heavy company?
    • What is the 52 week high and low for Natural Capsules?
    • Should I rely only on this article before investing in Natural Capsules?

Natural Capsules Bull Case: Why Natural Capsules Could Move Higher

Building the Natural Capsules bull case means looking closely at the metrics investors watch most: valuation, profitability, leverage, and price momentum. Here is what supports the Natural Capsules bull case for Natural Capsules shares right now.

Trading Close to Book Value: Natural Capsules trades at a book value of Rs 168.08 per share against a market price of Rs 172.16, meaning the stock is not trading at a significant premium to its accounting net worth.

Neutral Technical Setup: With the RSI near 47.14, the stock is not in an extreme technical zone in either direction.

Trading Above Its 52 Week Low: The stock trades above its 52 week low of Rs 136.36, suggesting some stabilisation in investor sentiment recently.

Taken together, these points form the core of the Natural Capsules bull case for Natural Capsules, though as with any thesis, they should be weighed against the risks on the other side.

Explore the Univest Stock Screener

The Bear Case: Risks Facing Natural Capsules

No Natural Capsules bull case is complete without an honest look at what could go wrong. The following factors form the bear case for Natural Capsules shares.

Sharp Single Session Decline: Natural Capsules fell more than 4.5 percent in the latest session, reflecting a significant burst of selling pressure in the pharmaceutical capsules business.

Ongoing Losses: The company reported a return on equity of negative 7.27 percent and negative earnings per share of Rs 23.85, reflecting a currently loss making business.

Moderate Leverage: A debt to equity ratio of 0.49 is on the higher side for a capsules manufacturer.

No Current Dividend: A 0 percent dividend yield means the stock currently offers no income cushion for shareholders.

Download the Univest iOS App or the Univest Android App to track this stock on the go.

Conclusion

The Natural Capsules bull case and the bear case for Natural Capsules both draw on the same set of numbers, valuation, return on equity, leverage, and price momentum, interpreted from opposite directions. At Rs 172.16, Natural Capsules shares sit in a 52 week range of Rs 136.36 to Rs 296.00, and where the stock goes from here will likely depend on which side of the Natural Capsules bull case versus bear case debate dominates investor sentiment. As with any stock, independent research and a clear view of your own risk tolerance should guide any final decision, and revisiting the Natural Capsules bull case periodically as new data emerges is a sound practice.

Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Univest Research Analyst services are provided under SEBI Registration No. INH000013776. Stock prices, financial ratios, and technical indicators mentioned above are as of 16 Sep 2026 and are subject to change; please verify all data independently before making any investment decision. Past performance is not indicative of future results. Investments in securities are subject to market risk.

Frequently Asked Questions

What is the Natural Capsules bull case for the stock?

Ans. The Natural Capsules bull case for Natural Capsules centers on trading close to book value, among other factors covered above, though investors should weigh this alongside the risks discussed in the bear case section.

What is the bear case for Natural Capsules shares?

Ans. The primary risk highlighted in the bear case is sharp single session decline, and investors should factor this in before making a decision.

What is the current share price of Natural Capsules?

Ans. Natural Capsules shares currently trade at Rs 172.16, within a 52 week range of Rs 136.36 to Rs 296.00.

What is the P/E ratio of Natural Capsules?

Ans. Natural Capsules trades at a P/E ratio of not meaningful (loss making), compared with a broader industry average of around 37.96.

What is the return on equity for Natural Capsules?

Ans. Natural Capsules reported a return on equity of -7.27 percent.

Is Natural Capsules a debt heavy company?

Ans. Natural Capsules carries a debt to equity ratio of 0.49, which investors can compare against sector peers to judge balance sheet risk.

What is the 52 week high and low for Natural Capsules?

Ans. Natural Capsules has a 52 week high of Rs 296.00 and a 52 week low of Rs 136.36.

Should I rely only on this article before investing in Natural Capsules?

Ans. No. This Natural Capsules bull case article presents both the Natural Capsules bull case and the bear case using publicly available fundamentals and technical data as of 16 Sep 2026, but you should verify all figures independently and consider consulting a registered investment adviser before making any investment decision.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply